Straits Times Index
3,313.48 +8.49 (+0.26%) S&P 500
5,303.27 +6.17 (+0.12%) Dow
40,003.59 +134.19 (+0.34%) Nasdaq
16,685.97 -12.33 (-0.07%) Bitcoin USD
66,372.09 -486.27 (-0.73%) CMC Crypto 200
1,355.14 -18.70 (-1.36%)
Becton, Dickinson and Company (BDX.VI)
| Previous close | 218.90 |
| Open | 218.10 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 216.80 - 218.10 |
| 52-week range | 213.00 - 261.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 62.841B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 50.54 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.55 (1.64%) |
| Ex-dividend date | 10 Jun 2024 |
| 1y target est | N/A |
- PR Newswire
Women in U.S. Can Now Collect Their Own Sample for Cervical Cancer Screening
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical specimens cannot otherwise be obtained. The approval allows women to self-collect vaginal specimens for HPV testing in a health care setting, which could include non-traditional locations such as a retail pharmacy or mobile clinic.
- PR Newswire
BD Reports Second Quarter Fiscal 2024 Financial Results
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal 2024, which ended March 31, 2024.
- PR Newswire
BD Board Declares Dividend
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on June 28, 2024 to holders of record on June 10, 2024. The indicated annual dividend rate is $3.80 per share.
